The Radioligand Flywheel From Multiparameter Optimization to Clinical Momentum

• AI navigates the multiparameter design space to identify promising radioligand profiles.
• Laboratory feedback improves every successive design cycle.
• Clinical insights connect patient-level evidence with the next generation of molecular designs.

Speakers:

Sigal Kalmanson Cusnir

Chief Executive Officer

Starget Pharma